Efficacy of Radiotherapy FLASH-RT: From Treating Lung Cancer to Preventing Pulmonary Fibrosis

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Conventional radiotherapy (CONV-RT) can cause significant toxicity to normal tissues.
• Pulmonary fibrosis is a common and serious complication following thoracic radiotherapy.
• FLASH radiotherapy (FLASH-RT) utilizes ultra-high dose rates for rapid radiation delivery.

Purpose of the Study:

• To review the recent findings and advancements in FLASH-RT.
• To evaluate the potential of FLASH-RT in mitigating normal tissue toxicity, particularly pulmonary fibrosis.
• To discuss the future prospects and unresolved challenges of FLASH-RT in clinical applications.

Main Methods:

• Review of experimental animal model data and recent scientific literature on FLASH-RT.
• Comparison of normal tissue responses between FLASH-RT and CONV-RT.
• Analysis of evidence regarding FLASH-RT's effect on pulmonary fibrosis development.

Main Results:

• FLASH-RT demonstrates potential for protecting normal tissues like the brain, gastrointestinal tract, and lungs from radiation-induced damage.
• Emerging evidence suggests FLASH-RT may prevent pulmonary fibrosis in lung cancer patients, unlike CONV-RT.
• Experimental data indicates a protective effect of FLASH-RT on normal tissues.

Conclusions:

• FLASH-RT presents a potentially safer and more effective alternative to CONV-RT.
• Further research and resolution of existing concerns are needed for widespread clinical adoption.
• FLASH-RT holds significant promise for improving lung cancer treatment outcomes by reducing side effects.